Citius Pharmaceuticals In...
(CTXR)
undefined
undefined%
At close: undefined
3.89
5.14%
After-hours Jan 08, 2025, 06:27 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Net Income | -39.43M | -32.54M | -33.64M | -23.05M | -17.55M | -15.56M | -12.54M | -10.38M | -8.30M | -2.90M | -1.27M | -31.37K | -22.01K | -26.34K |
| Depreciation & Amortization | 209.61K | 194.32K | 179.68K | 164.87K | 152.36K | 893.00 | 1.75K | 2.63K | 1.34K | n/a | n/a | n/a | n/a | n/a |
| Stock-Based Compensation | 11.84M | 6.62M | 3.91M | 1.45M | 803.26K | 715.98K | 779.70K | 986.62K | 732.15K | 486.27K | 470.19K | n/a | n/a | n/a |
| Other Working Capital | -1.55M | -5.77M | 351.27K | -2.14M | -9.66K | 1.06M | -461.17K | 422.24K | 562.93K | -90.31K | 164.57K | -709 | 2.59K | 4.65K |
| Other Non-Cash Items | 284.18K | 102.00K | 378.20K | 68.00K | 528.77K | 211.60K | 377.20K | 1.31M | 150.00K | -332.10K | -67.66K | 103.10K | 131.63 | -26.34K |
| Deferred Income Tax | 576.00K | 576.00K | 576.00K | -166.56K | n/a | n/a | -450.00K | n/a | 843.62K | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | -1.69M | -4.01M | 239.56K | -2.72M | -866.97K | 2.20M | 509.85K | 115.52K | 668.16K | 362.68K | 164.57K | 10.77K | 1.68K | 5.56K |
| Operating Cash Flow | -28.20M | -29.06M | -28.36M | -24.25M | -16.93M | -12.44M | -11.32M | -7.97M | -5.90M | -2.39M | -705.05K | -20.60K | -20.32K | -20.78K |
| Capital Expenditures | n/a | 2.00 | n/a | -40.01M | -1.83K | n/a | n/a | -2.13K | n/a | n/a | n/a | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 255.75K | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -5.00M | n/a | n/a | -40.00K | n/a | n/a | n/a | n/a | 255.75K | n/a | n/a | n/a | -2.02 | n/a |
| Investing Cash Flow | -5.00M | n/a | n/a | -40.01M | -1.83K | n/a | n/a | -2.13K | 255.75K | n/a | n/a | n/a | -2.02 | n/a |
| Debt Repayment | n/a | n/a | n/a | -172.97K | 164.58K | n/a | n/a | 4.21M | -100.00K | n/a | n/a | 20.47K | 20.25K | -8.75K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 9.97M | 31.27K | n/a | 31.21M | 7.16M | 23.22K | 1.13M | 6.67M | -64.80K | n/a | 2.26M | n/a | n/a | 27.24K |
| Financial Cash Flow | 9.97M | 13.83M | n/a | 120.47M | 22.90M | 11.15M | 17.30M | 10.88M | 5.26M | 1.51M | 2.26M | 20.47K | 20.25K | 18.49K |
| Net Cash Flow | -23.23M | -15.23M | -28.36M | 56.21M | 5.97M | -1.29M | 5.98M | 2.91M | -381.79K | -875.92K | 1.55M | 54.26K | -77 | -2.29K |
| Free Cash Flow | -28.20M | -29.06M | -28.36M | -64.26M | -16.93M | -12.44M | -11.32M | -7.97M | -5.90M | -2.39M | -705.05K | -20.60K | -20.32K | -20.78K |